Uveal Melanoma Clinical Trials in the UK

Uveal Melanoma Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 7 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

NCT07015190Uveal Melanoma

IDEAYA Biosciences

Phase 3

520

Metropolitan Borough of Wirral, London, Sheffield

2026-01-25

Active, closed

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

NCT06717126Uveal Melanoma, Ocular Melanoma

iOnctura

Phase 2

Northwood, Bebington, Glasgow, London, Southampton

2025-02-27

Active, closed

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

NCT06007690Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma

Aura Biosciences

Phase 3

108

London, Sheffield

2023-12-06

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/uveal-melanoma

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →